Piet ter Wee
About
In The Last Decade
Piet ter Wee
10 papers receiving 751 citations
Hit Papers
Peers
Comparison fields: 5 of 59
- Emergency Medical Services 557
- Nephrology 461
- Pulmonary and Respiratory Medicine 421
- Surgery 334
- Cardiology and Cardiovascular Medicine 118
Countries citing papers authored by Piet ter Wee
This map shows the geographic impact of Piet ter Wee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piet ter Wee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piet ter Wee more than expected).
Fields of papers citing papers by Piet ter Wee
This network shows the impact of papers produced by Piet ter Wee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piet ter Wee. The network helps show where Piet ter Wee may publish in the future.
Co-authorship network of co-authors of Piet ter Wee
This figure shows the co-authorship network connecting the top 25 collaborators of Piet ter Wee. A scholar is included among the top collaborators of Piet ter Wee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piet ter Wee. Piet ter Wee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | INCREASED PLASMA FIBROBLAST GROWTH FACTOR 23 IS ASSOCIATED WITH AN IMPAIRED RESPONSE TO ANTIPROTEINURIC THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE | 4 |
| 7 | The role of renal function loss on circadian misalignment of cytokines EPO, IGF-1, IL-6 and TNF-alfa in chronic renal disease. | 2 |
| 8 | 221 | |
| 9 | EBPG on Vascular Access breakdown → | 502 |
| 10 | 34 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.